Travera
PrivateLast Round
Series A
Dec 22, 2023
Total Funding Raised
$30.21M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Travera is a biotechnology company that provides a cancer therapy guidance test utilizing single-cell measurement technology to assess tumor cell responses to potential drug treatments in real-time.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine, Medical Devices
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Travera Comparables
Compare Travera with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| First Ascent Biomedical | 89% | |
| SageMedic Corp. | 84% | |
| Eutropics Pharmaceuticals | 84% | |
Travera Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Dec 22, 2023 | ||||
| Accelerator | Jun 6, 2023 | ||||
| Series A Extension | Jul 15, 2021 | ||||
| Grant | Sep 15, 2020 | ||||
| Grant | Jun 1, 2019 | ||||
Grant | Feb 1, 2019 |
Key People
Founding team and executive leadership
Travera Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Cancer Institute | Grant |
| Horizons Ventures | Series A, Series A Extension |
| MAS Capital | Series A, Series A Extension |
| MedTech Innovator | Accelerator |
| Khosla Ventures | Series A, Series A Extension |
| National Science Foundation | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 26, 2026
Monthly visitors increased 58% MoM.
- May 15, 2026
Monthly visitors grew 301% MoM, reaching 1.9K.
Travera Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Travera's valuation, stock price, and market status.